CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Revenue:
Total revenue	$ 3,828,326	$ 3,180,187
Cost of revenue:
Total cost of revenue	649,007	547,380
Gross profit	3,179,319	2,632,807
Operating expenses:
Research and development costs	659,940	674,924
Selling and marketing	1,396,640	981,191
General and administrative	837,867	1,093,169
Restructuring costs	302,313	287,460
Total operating expenses	3,196,760	3,036,744
Operating income (loss)	(17,441)	(403,937)
Gain on debt extinguishment	754,000	0
Interest and other expense	(266,695)	(245,839)
Income (loss) before income taxes	469,864	(649,776)
Income tax expense (benefit)	44,616	70,064
Net income (loss)	425,248	(719,840)
Less: Accrual of Series A redeemable convertible preferred stock dividends	277,170	285,760
Less: Accretion to redemption value of Series A redeemable convertible preferred stock	197,114	26,090
Net income (loss) attributable to common stockholders	$ (49,036)	$ (1,031,690)
Basic net income (loss) per share attributable to common stockholders	$ (0.01)	$ (0.17)
Diluted net income (loss) per share attributable to common stockholders	$ (0.01)	$ (0.17)
Weighted average basic shares outstanding	5,949,463	5,919,643
Weighted average diluted shares outstanding	5,949,463	5,919,643
Product revenue
Revenue:
Total revenue	$ 2,139,729	$ 1,048,963
Cost of revenue:
Total cost of revenue	222,834	139,460
Support and services revenue
Revenue:
Total revenue	1,688,597	2,131,224
Cost of revenue:
Total cost of revenue	$ 426,173	$ 407,920